SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

SAN

77.5

-0.64%↓

UCB

245.7

-2.15%↓

SHL.DE

36.54

-1.67%↓

ARGX

586.2

-0.71%↓

VIE

31.08

-1.8%↓

Strona główna・Stock List・Nanobiotix

N
Nanobiotix

Closed

25.65 -5.7

Buy Sell

Overview

Share price change

24h

Current

Min

25.45

Max

27.75

Key metrics
By Trading Economics
Income	-5.4M
Sales	27M
Profit margin	-20.208
Employees	103
EBITDA	1.1M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-16.06% downside

Dividends
By Dow Jones
Next Earnings	1 kwi 2026

Market Stats
By TradingEconomics
Market Cap	1.4B
Previous open	31.35
Previous close	25.65

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

2.975 / 3.015 Support & Resistance

Nanobiotix Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 mar 2026, 17:19 UTC

Major News Events

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20 mar 2026, 16:56 UTC

Major News Events

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20 mar 2026, 16:56 UTC

Major News Events

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20 mar 2026, 16:45 UTC

Major News Events

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20 mar 2026, 16:22 UTC

Major News Events

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

20 mar 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

20 mar 2026, 20:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

20 mar 2026, 19:55 UTC

Market Talk

Major News Events

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20 mar 2026, 19:28 UTC

Market Talk

Major News Events

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20 mar 2026, 19:28 UTC

Acquisitions, Mergers, Takeovers

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mar 2026, 18:39 UTC

Market Talk

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20 mar 2026, 18:31 UTC

Acquisitions, Mergers, Takeovers

Honeywell Announces Pricing of Debt Tender Offers >HON

20 mar 2026, 18:19 UTC

Acquisitions, Mergers, Takeovers

Why Mayo and Soap No Longer Mix for Unilever -- Update

20 mar 2026, 18:15 UTC

Market Talk

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20 mar 2026, 17:57 UTC

Market Talk

U.S. Oil Rig Count Inches Up -- Market Talk

20 mar 2026, 17:04 UTC

Major News Events

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20 mar 2026, 16:20 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

20 mar 2026, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

20 mar 2026, 15:40 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20 mar 2026, 15:30 UTC

Earnings

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20 mar 2026, 15:26 UTC

Market Talk

Earnings

Major News Events

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20 mar 2026, 15:26 UTC

Acquisitions, Mergers, Takeovers

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20 mar 2026, 15:25 UTC

Market Talk

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20 mar 2026, 15:19 UTC

Market Talk

Major News Events

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20 mar 2026, 14:58 UTC

Major News Events

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20 mar 2026, 14:55 UTC

Market Talk

Major News Events

Gold Lower as Speculative Pullback Extends -- Market Talk

20 mar 2026, 14:54 UTC

Acquisitions, Mergers, Takeovers

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20 mar 2026, 14:53 UTC

Acquisitions, Mergers, Takeovers

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

20 mar 2026, 14:46 UTC

Market Talk

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

20 mar 2026, 14:45 UTC

Market Talk

Major News Events

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Peer Comparison

Price change

Nanobiotix Forecast

Price Target

By TipRanks

-16.06% downside

12 Months Forecast

Average 23 EUR -16.06%

High 23 EUR

Low 23 EUR

Based on 1 Wall Street analysts offering 12 month price targets forNanobiotix - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Nanobiotix - Dist in the past 3 months.

Technical Score

By Trading Central

2.975 / 3.015Support & Resistance

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.